Key facts
| Price (PPV) | 18.30 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | chlorhydrate de cinchocaïnehydrocortisoneacétate d’hydrocortisoneesculosidebenzocaine |
| Class | Anti-hémorroïdaire |
| Manufacturer | SYNTHEMEDIC |
| Presentation | Tube de 10 g |
| Nature | Médicament |
| Hospital price | 11.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Ce médicament est une association d’un corticoïde et d’un anesthésique local (pommade et suppositoires) et d’un veinotonique (suppositoires). Ce médicament est préconisé dans certaines pathologies anales s’accompagnant de douleurs ou de démangeaisons, en particulier dans la crise hémorroïdaire.
Find an open pharmacy
On-call pharmacies near you
About Hemofast
Hemofast belongs to the anti-hémorroïdaire therapeutic class. In Morocco, this drug is marketed by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Hemofast, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Hemofast
Answers to common questions from Moroccan patients about this drug.